Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **synovial joint** (also known as diarthrosis) is the most common and movable type of joint in the human body. It consists of two or more bones whose articulating ends are covered with smooth, glass-like hyaline cartilage to reduce friction. The bones are surrounded by a fibrous synovial capsule, lined with a synovial membrane that secretes synovial fluid for lubrication and nourishment, acting as a shock absorber. The joint cavity is surrounded by ligaments that provide support and restrict excessive movement. Synovial joints are essential for smooth, pain-free movement and include structures such as the elbow, knee, shoulder, and hip joints[1][2][4][5]. **Note**: "Synovial joint" is not a valid molecular or receptor target; it is an anatomical structure composed of various tissues. If you need information on specific molecular targets relevant to joint biology (e.g., synovial membrane, cartilage proteins, inflammatory mediators), please request information on those molecules or receptors directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synovial joint.